1. Home
  2. IBIO vs KUKE Comparison

IBIO vs KUKE Comparison

Compare IBIO & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBIO
  • KUKE
  • Stock Information
  • Founded
  • IBIO 2008
  • KUKE 2002
  • Country
  • IBIO United States
  • KUKE China
  • Employees
  • IBIO N/A
  • KUKE N/A
  • Industry
  • IBIO Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • IBIO Health Care
  • KUKE Real Estate
  • Exchange
  • IBIO Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • IBIO 23.4M
  • KUKE 21.2M
  • IPO Year
  • IBIO N/A
  • KUKE 2021
  • Fundamental
  • Price
  • IBIO $2.30
  • KUKE $0.40
  • Analyst Decision
  • IBIO Strong Buy
  • KUKE
  • Analyst Count
  • IBIO 2
  • KUKE 0
  • Target Price
  • IBIO $4.30
  • KUKE N/A
  • AVG Volume (30 Days)
  • IBIO 97.9K
  • KUKE 1.1M
  • Earning Date
  • IBIO 11-12-2024
  • KUKE 12-26-2024
  • Dividend Yield
  • IBIO N/A
  • KUKE N/A
  • EPS Growth
  • IBIO N/A
  • KUKE N/A
  • EPS
  • IBIO N/A
  • KUKE N/A
  • Revenue
  • IBIO $175,000.00
  • KUKE $14,784,158.00
  • Revenue This Year
  • IBIO N/A
  • KUKE N/A
  • Revenue Next Year
  • IBIO N/A
  • KUKE N/A
  • P/E Ratio
  • IBIO N/A
  • KUKE N/A
  • Revenue Growth
  • IBIO 250.00
  • KUKE 10.48
  • 52 Week Low
  • IBIO $0.25
  • KUKE $0.33
  • 52 Week High
  • IBIO $6.20
  • KUKE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • IBIO 40.07
  • KUKE 37.88
  • Support Level
  • IBIO $2.40
  • KUKE $0.38
  • Resistance Level
  • IBIO $2.65
  • KUKE $0.54
  • Average True Range (ATR)
  • IBIO 0.21
  • KUKE 0.12
  • MACD
  • IBIO -0.07
  • KUKE -0.01
  • Stochastic Oscillator
  • IBIO 27.49
  • KUKE 10.75

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: